日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies

Bimekizumab 在成人中轴型脊柱关节炎或银屑病关节炎患者中的长期安全性:六项 IIb/III 期临床研究的最新分析

Mease, Philip J; Merola, Joseph F; Magrey, Marina; Nash, Peter; Poddubnyy, Denis; Lebwohl, Mark; Bajracharya, Rajan; Ink, Barbara; Marten, Alexander; Manente, Myriam; Peterson, Luke; White, Katy; Gensler, Lianne S

Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials

HLA-B27状态是否影响伊克珠单抗治疗中轴型脊柱关节炎的疗效?来自COAST-V、COAST-W和COAST-X试验的结果

Reveille, John D; Rudwaleit, Martin; Rahman, Proton; Maldonado-Cocco, Jose A; Magrey, Marina; Bolce, Rebecca; Ng, Khai Jing; Gibble, Theresa Hunter; Lisse, Jeffrey; Park, So Young; Kronbergs, Andris; Navarro-Compán, Victoria

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

银屑病关节炎表型聚类及其与治疗反应的关系:来自银屑病关节炎研究联盟的真实世界纵向队列研究

Karmacharya, Paras; Crofford, Leslie J; Byrne, Daniel W; Stephens-Shields, Alisa; Husni, M Elaine; Scher, Jose U; Craig, Ethan; Fitzsimmons, Robert; Reddy, Soumya M; Magrey, Marina N; Walsh, Jessica A; Ogdie, Alexis

Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies

在患有中轴型脊柱关节炎的患者中,使用比美珠单抗治疗可持续改善脊柱疼痛、晨僵、疲劳、睡眠、身体功能和整体健康相关生活质量:两项 3 期研究的 2 年结果

Marzo-Ortega, Helena; Navarro-Compan, Victoria; Dubreuil, Maureen; Mease, Philip J; Magrey, Marina; Rudwaleit, Martin; D'Agostino, Maria-Antonietta; Gaffney, Karl; Kay, Jonathan; de la Loge, Christine; Massow, Ute; Taieb, Vanessa; Vaux, Tom; Deodhar, Atul

A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment

一项针对强直性脊柱炎患者(治疗16周后未达到疾病非活动期)的司库奇尤单抗剂量递增研究

Deodhar, Atul; Kivitz, Alan J; Magrey, Marina; Walsh, Jessica A; Mease, Philip J; Greenwald, Maria; Kianifard, Farid; Elam, Chelsea; Bommidi, Gopi M; Winseck, Adam; Gensler, Lianne S

Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies

比美珠单抗治疗中轴型脊柱关节炎的长期安全性和有效性:两项3期研究的2年结果

Baraliakos, Xenofon; Deodhar, Atul; van der Heijde, Désirée; Van den Bosch, Filip; Magrey, Marina; Maksymowych, Walter P; Tomita, Tetsuya; Xu, Huji; Massow, Ute; Vaux, Tom; Prajapati, Chetan; Manente, Myriam; Marten, Alexander; Gensler, Lianne S

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration

无论症状持续时间长短,伊克珠单抗都能改善中轴型脊柱关节炎患者的体征、症状和生活质量。

Navarro-Compán, Victoria; Reveille, John D; Rahman, Proton; Maldonado-Cocco, José A; Magrey, Marina; Bolce, Rebecca; Panni, Tommaso; Kronbergs, Andris; Rudwaleit, Martin

Active screening of presumptive tuberculosis cases in rural communities through youth club members in India: logic model development and feasibility study

在印度农村社区通过青年俱乐部成员对疑似结核病病例进行主动筛查:逻辑模型开发和可行性研究

Anand, Praveen Kumar; Singh, Manjula; Kumar, Amber; Sahay, Seema; Pandey, Dhruvendra; Tiwari, Hitesh; Pappu, Anurag; Das, V N R; Gupta, Sarika; Bangar, Sampada; Ghosh, Brajraj; Magrey, Ashiq

Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data

轴性脊柱关节炎患者的诊断历程和确诊时间:一项基于美国医疗保险索赔数据的回顾性队列研究

Dubreuil, Maureen; Magrey, Marina; Haeffs, Kathrin; Ivanov, Evgueni; Gandrup Horan, Julie

Psychosocial burden of axial spondyloarthritis and impact of different disease domains: a systematic literature review

中轴型脊柱关节炎的心理社会负担及不同疾病领域的影响:系统性文献综述

Poddubnyy, Denis; Kiltz, Uta; Danve, Abhijeet; Wright, Grace; Haberman, Rebecca; Biljan, Ana; Clewell, Jerry; Urbanik, Jamie; Jones, Heather; Magrey, Marina